With this Senior Scientist Research and Mentorship Award (KO5), the Candidate will provide mentorship to 3- 5 faculty interested in interdisciplinary alcohol research. Preference will be given to junior faculty or faculty with strong disciplinary training who are new to the alcohol area. The Candidate already has a sustained track record of successful mentorship and scientific leadership in the alcohol field. Mentorship will include guidance on grant writing and other skills, the development of their research program, professional development and how to effectively work within interdisciplinary teams. In order to sustain the Candidate's performance as a scientific leader, the Candidate will continue extensive collaborations in interdisciplinary research at Yale University and nationally. Continued scientific growth will benefit from activities related to research mentoring and participation in research review and advisory group participation. Additionally, the PI will continue her contributions to the alcoholism field through clinical research on psychotherapeutic interventions, pharmacotherapy development, and human bio-behavioral laboratory studies. The reciprocal influence of alcohol and tobacco use will be considered in this program of research. As an example, the research plan presents a R01 funded study of naltrexone and BASICS counseling to reduce heavy drinking by young adults ages 18-25. This study integrates information on naltrexone derived from basic research, human laboratory studies, survey studies, and clinical trials to optimize its use for young adults who receive brief counseling to motivate and teach skills for reducing their drinking. Demonstration of the efficacy of naltrexone in this population will provide the essential information for its adoption by college counseling centers and other health care settings committed to reducing the risk of heavy drinking in young adults. Ultimately, early intention during this critical period may have long term benefits by altering trajectories of drinking. Plans for future research include secondary analyses of existing clinical trials, using human laboratory paradigms to screen new medications for alcohol dependence and clinical trials of promising compounds.

Public Health Relevance

An interdisciplinary approach to understanding and addressing hazardous alcohol use and alcohol dependence has the potential to substantially improve the effectiveness of prevention and treatment of alcohol dependence. This award will help train new investigators in interdisciplinary alcohol research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Scientist Award (K05)
Project #
5K05AA014715-10
Application #
8515879
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Roach, Deidra
Project Start
2004-04-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
10
Fiscal Year
2013
Total Cost
$228,147
Indirect Cost
$16,900
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Gueorguieva, Ralitza; Wu, Ran; O'Connor, Patrick G et al. (2014) Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT. Alcohol Clin Exp Res 38:2647-56
Leeman, Robert F; Ralevski, Elizabeth; Limoncelli, Diana et al. (2014) Relationships between impulsivity and subjective response in an IV ethanol paradigm. Psychopharmacology (Berl) 231:2867-76
Leeman, Robert F; Patock-Peckham, Julie A; Hoff, Rani A et al. (2014) Perceived parental permissiveness toward gambling and risky behaviors in adolescents. J Behav Addict 3:115-23
Park, Aesoon; O'Malley, Stephanie S; King, Sarah L et al. (2014) Mediating role of stress reactivity in the effects of prenatal tobacco exposure on childhood mental health outcomes. Nicotine Tob Res 16:174-85
Jatlow, Peter I; Agro, Ann; Wu, Ran et al. (2014) Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res 38:2056-65
O'Malley, Stephanie S; Wu, Ran; Mayne, Susan T et al. (2014) Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine Tob Res 16:1145-9
DeMartini, Kelly S; Leeman, Robert F; Corbin, William R et al. (2014) A new look at risk-taking: using a translational approach to examine risk-taking behavior on the balloon analogue risk task. Exp Clin Psychopharmacol 22:444-52
DeMartini, Kelly S; Devine, Eric G; DiClemente, Carlo C et al. (2014) Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs 75:438-46
Leeman, Robert F; Hoff, Rani A; Krishnan-Sarin, Suchitra et al. (2014) Impulsivity, sensation-seeking, and part-time job status in relation to substance use and gambling in adolescents. J Adolesc Health 54:460-6
Geha, Paul Y; Aschenbrenner, Katja; Felsted, Jennifer et al. (2013) Altered hypothalamic response to food in smokers. Am J Clin Nutr 97:15-22

Showing the most recent 10 out of 73 publications